# Royal Peptides Review 2026: Research Peptide Catalog, Quality Standards, and Supplier Analysis
> Research Use Only (RUO) Disclaimer: All products discussed in this review are sold exclusively for laboratory research and in-vitro scientific investigation. They are not approved for human or veterinary use, and are not intended for clinical application or self-administration. This review is intended for qualified researchers operating within applicable institutional protocols and regulatory frameworks.
Royal Peptides is a U.S.-based research peptide supplier that has built a catalog of over 66 active listings spanning the major compound families studied in modern peptide science. From growth hormone secretagogues and tissue repair peptides to GLP-1 receptor agonists and cognitive compounds, Royal Peptides positions itself as a broad-spectrum research supplier with a quality-first orientation. This review examines the supplier's catalog depth, testing documentation practices, pricing model, ordering experience, and overall value proposition for researchers sourcing compounds in 2026.
---
Company Overview
Royal Peptides operates as a domestic U.S. research compound supplier, accessible at royal-peptides.com. The brand's positioning around the "Royal" name signals an aspiration toward premium quality — purity, analytical verification, and supply consistency aligned with the expectations of institutional and independent research settings.
The supplier carries 66+ active listings on Peptides.SO, placing it in the upper tier of catalog depth among U.S. domestic peptide suppliers. Its compound categories span growth hormone biology, tissue repair, metabolic science, melanocortin pharmacology, longevity research, and cognitive neuroscience, making it a viable single-source option for research programs that span multiple peptide biology domains.
Royal Peptides joined the Peptides.SO marketplace in March 2026 and currently holds an unclaimed supplier profile, meaning the operational data presented here is based on verified catalog scraping and available product documentation rather than supplier-submitted materials.
---
Catalog Analysis: 66+ Listings Across Six Research Categories
The Royal Peptides catalog covers the principal research peptide compound families with meaningful depth in each segment.
Growth Hormone Secretagogue Compounds
The GHS segment is where Royal Peptides demonstrates particularly strong coverage. The catalog includes:
- •CJC-1295 (with and without DAC) — GHRH analogue studied in GH pulse modulation and IGF-1 secretion research
- •Ipamorelin — selective GHRP studied for GH release with minimal cortisol and prolactin activity
- •GHRP-2 and GHRP-6 — classical growth hormone releasing peptides with established preclinical literature in GH axis pharmacology
- •Hexarelin — potent GHRP analogue studied in cardiac function and GH secretion research
- •Sermorelin — endogenous GHRH analogue with a well-characterized receptor binding profile
- •MK-677 (Ibutamoren) — oral GH secretagogue studied in non-injectable GH axis activation models
This represents a nearly complete GHRH/GHRP compound panel, positioning Royal Peptides as a reliable source for researchers working on GH axis biology, somatotroph function, and IGF-1 pathway studies.
Tissue Repair and Regeneration Peptides
Royal Peptides carries both BPC-157 (Body Protective Compound-157) and TB-500 (Thymosin Beta-4) in lyophilized vial formats as well as in blended combination products. These peptides are among the most studied repair compounds in the preclinical literature, with research spanning:
- •Tendon and ligament repair models
- •Gastrointestinal mucosal protection
- •Cardiac tissue healing
- •Systemic anti-inflammatory peptide activity
The availability of combination products (BPC-157 + TB-500 blends) reflects market demand from researchers studying synergistic repair biology across these two compound classes. The catalog's Healing & Growth category contains 41 listings, making it the largest single category segment — a clear indicator of where Royal Peptides has invested the most catalog depth.
GLP-1 and Metabolic Research Compounds
Royal Peptides supports researchers in the contemporary metabolic disease research space with compounds including:
- •Semaglutide — GLP-1 receptor agonist (active ingredient in FDA-approved Ozempic/Wegovy) studied in insulin secretion, appetite regulation, and energy balance research
- •Tirzepatide — dual GIP/GLP-1 receptor agonist (FDA-approved as Mounjaro) studied in multi-incretin pharmacology and metabolic syndrome models
- •Retatrutide — investigational triple GIP/GLP-1/glucagon receptor agonist (Eli Lilly LY3437943, currently in Phase 3 clinical trials) studied in weight loss pharmacology and metabolic disease biology
The GLP/GIP Research category contains 10 listings, reflecting meaningful commitment to the metabolic compound research segment that has driven significant researcher demand since 2023.
Melanocortin and Pigmentation Research Compounds
Melanocortin compound coverage includes:
- •Melanotan I — alpha-MSH analogue studied in melanocyte stimulation and UV-protective pigmentation biology
- •Melanotan II — non-selective MC receptor agonist with research applications in pigmentation, energy balance, and MC receptor pharmacology
- •PT-141 (Bremelanotide) — melanocortin receptor agonist approved by the FDA in 2019 (Vyleesi) for hypoactive sexual desire disorder, with ongoing research interest in MC receptor CNS biology
Longevity and Bioregulator Compounds
Royal Peptides carries several compounds studied in longevity and cellular regulation research:
- •Epithalon — tetrapeptide studied in telomere length regulation and pineal gland function research
- •Thymosin Alpha-1 — thymic peptide studied in immune modulation and cytokine regulation research
- •GHK-Cu — copper tripeptide studied in wound healing, collagen synthesis, and skin biology research
Cognitive Research Compounds
The cognitive peptide segment includes Semax and Selank, two compounds with substantial preclinical literature in:
- •Neuroprotection and BDNF/NGF signaling modulation
- •Anxiety-related CNS biology in animal models
- •Cognitive performance and stress response research in rodent models
This coverage positions Royal Peptides as a viable source for researchers working at the intersection of neurotrophin biology and therapeutic peptide pharmacology.
Ancillary Supplies
The catalog includes bacteriostatic water and reconstitution supplies, supporting standard laboratory compound preparation procedures without requiring researchers to source ancillary materials from a separate supplier.
---
Quality Assurance and Testing Documentation
Royal Peptides states a commitment to third-party HPLC and mass spectrometry analytical testing for purity verification. For research peptide suppliers, the quality documentation framework is a critical differentiator — COA and HPLC data allow researchers to verify that compounds meet acceptable purity thresholds before use in experimental protocols.
Testing Standards
HPLC (High-Performance Liquid Chromatography) analysis identifies compound purity by separating the target peptide from synthesis byproducts, truncation sequences, and other contaminants. Mass spectrometry (MS) confirms molecular identity by verifying the compound's molecular weight against the expected theoretical mass. Together, these two analytical methods represent the baseline quality documentation framework for reputable research peptide suppliers.
Testing Score and COA Availability
Royal Peptides currently holds a testing score of 0 in the Peptides.SO verification system, which reflects the absence of independently submitted COA documentation in the marketplace's verification database at the time of this review. This is a common status for suppliers that are newer to the marketplace or that have not yet submitted documentation through the platform's formal verification process.
Researchers sourcing from Royal Peptides should request batch-specific COA documentation directly from the supplier prior to initiating compound orders, and verify that provided documentation includes HPLC purity percentage, MS confirmation of molecular identity, and batch identification numbers.
---
Pricing and Value Analysis
Royal Peptides operates on the USD pricing model with compound availability in both single vial and multi-vial kit formats. The catalog includes a 10-Vial Kit category (36 listings) and a Single Vials category (25 listings), offering researchers options for both trial-scale and bulk research procurement.
Bulk Kit Pricing Structure
The availability of 10-vial bulk kits is a meaningful pricing advantage for research programs running extended compound studies. Bulk kit pricing typically reduces the per-unit cost compared to single vial purchasing, making it cost-effective for researchers who have validated a compound and are moving into sustained experimental protocols.
Canada Stock Availability
The Canada Stock category (11 listings) indicates Royal Peptides maintains inventory positioned for Canadian researcher access — relevant for research institutions in Canada seeking domestic-origin supply chains with reduced international shipping complexity.
Payment Methods
Royal Peptides accepts check and wire transfer as payment methods. This payment structure is typical for research peptide suppliers operating under standard domestic commercial frameworks, though it may add processing time compared to suppliers accepting card payments. Researchers should factor payment processing timelines into procurement planning for time-sensitive experimental schedules.
---
Ordering Process and Logistics
Website and Catalog Navigation
Royal Peptides operates via royal-peptides.com. The WooCommerce-based catalog (61 products synced as of March 2026) provides standard product browse, category filtering, and cart checkout functionality.
The catalog's category structure — including Best Sellers (19), New Arrivals (13), Immune & Wellness (13), and Peptide Blends (6) — offers researchers multiple navigation paths to locate compounds relevant to their specific research focus.
Shipping and Fulfillment
Shipping method details are not currently specified in available supplier documentation. Researchers should contact Royal Peptides directly to confirm shipping carriers, estimated delivery timelines, packaging standards (dry ice for lyophilized peptides), and any handling requirements relevant to compound stability.
---
Pros and Cons Summary
Pros
- •Broad catalog depth — 66+ listings spanning six major research peptide categories
- •Complete GHS coverage — CJC-1295 (DAC and no-DAC), Ipamorelin, GHRP-2/6, Hexarelin, Sermorelin, MK-677
- •GLP-1 and metabolic research support — Semaglutide, Tirzepatide, Retatrutide for contemporary metabolic biology research
- •Bulk kit availability — 10-vial kit pricing for cost-effective extended research procurement
- •U.S. domestic supplier — domestic supply chain with Canada Stock availability
- •Cognitive peptide coverage — Semax and Selank for neuroprotection and CNS biology research
- •Third-party HPLC and MS testing — analytical testing framework stated for purity verification
- •Ancillary supplies included — bacteriostatic water eliminates need for separate sourcing
Cons
- •Payment limited to check/wire — no card payment options, which may slow procurement timelines
- •Unverified COA documentation — no independently submitted COA documentation in Peptides.SO verification database at time of review; researchers should request batch-specific COA directly
- •Unclaimed supplier profile — operational details (shipping timelines, return policy, customer service responsiveness) not verifiable through supplier-submitted documentation
- •No published pricing data — per-compound pricing not available in current catalog data; researchers must visit royal-peptides.com for current pricing
- •No customer reviews yet — 0 reviews in the Peptides.SO review system; purchase experience feedback not available from community data
---
Verdict: Strong Catalog Depth, Verification Documentation Recommended
Royal Peptides enters the 2026 research peptide marketplace with a catalog that covers the core compound families researchers rely on — a rare combination of GHS breadth, repair peptide depth, GLP-1 metabolic compounds, melanocortin coverage, longevity bioregulators, and cognitive peptides in a single domestic U.S. supplier.
The supplier's stated commitment to third-party HPLC and mass spectrometry testing aligns with baseline quality standards for research peptide sourcing. The primary gap in Royal Peptides' current marketplace profile is the absence of independently verified COA documentation in the Peptides.SO verification system — a status that will likely improve as the supplier engages with the marketplace's formal verification process.
Recommended for: Researchers seeking a broad-catalog domestic U.S. peptide supplier for GHS, repair biology, GLP-1 metabolic research, or longevity compound studies who are prepared to verify batch-specific COA documentation directly with the supplier.
Not yet recommended without verification for: Research programs requiring marketplace-validated COA documentation before procurement authorization.
Overall, Royal Peptides represents a compelling catalog option in the 2026 U.S. research peptide marketplace, with the compound coverage and quality orientation to serve institutional and independent research programs across the principal peptide biology domains.
---
All products referenced in this review are sold for research use only (RUO). They are not approved by the FDA or any other regulatory authority for human or veterinary use. This content is intended for qualified researchers and scientific professionals operating within applicable institutional and regulatory frameworks. Peptides.SO does not endorse, recommend, or facilitate the purchase of any compound for non-research purposes.